Volume 16, Issue 5 , Pages 216-219, September 2007
Echocardiography in Patients With Symptomatic Intracranial Stenosis
Background: Echocardiography is often performed in patients with stroke, even when alterative stroke causes are identified. We evaluated the use of echocardiography in patients with transient ischemic attack (TIA) or stroke caused by stenosis of a major intracranial artery. Methods: The Warfarin Versus Aspirin for Symptomatic Intracranial Disease (WASID) trial was a National Institutes of Health–funded, randomized, double-blind, multicenter clinical trial in which 569 patients with TIA or ischemic stroke attributed to angiographically proven 50% to 99% stenosis of a major intracranial artery were randomly assigned to warfarin or aspirin. Patients with unequivocal cardiac sources of embolism were excluded. The risk of ischemic stroke, myocardial infarction, and vascular death was compared among patients who had or did not have echocardiography performed before enrollment, and Cox proportional hazards models were used to determine whether echocardiographic abnormalities present in greater than 5% of patients were associated with these outcomes. Results: In all, 264 of 569 patients in WASID had echocardiograms; 37% were transesophageal. Of these 264 patients, 69 had subsequent ischemic stroke, myocardial infarction, or vascular death. Patients who underwent echocardiography had similar event rates to those who did not (P = .18). Common abnormalities identified on echocardiography were not associated with subsequent risk in this population. Conclusions: Among patients with TIA or stroke caused by intracranial arterial stenosis, echocardiography appears to offer limited diagnostic and prognostic value.
Key Words: Stroke, echocardiography, intracranial stenosis, cardioembolism
To access this article, please choose from the options below
Supported by a research grant (1R01 NS36643, Principal Investigator: Chimowitz MI) from the US Public Health Service, National Institute of Neurological Disorders and Stroke (NINDS). In addition, the following General Clinical Research centers, funded by the National Institutes of Health, provided local support for the evaluation of patients in the trial: Emory University (M01 RR00039), Case Western University, MetroHealth Medical Center (5M01 RR00080), San Francisco General Hospital (M01 RR00083-42), Johns Hopkins University School of Medicine (M01 RR000052), Indiana University School of Medicine (5M01 RR000750-32), Cedars–Sinai Hospital (M01 RR00425), and the University of Maryland (M01 RR165001).
See appendix of reference 9 for list of WASID Investigators.
PII: S1052-3057(07)00102-4
doi:10.1016/j.jstrokecerebrovasdis.2007.07.002
© 2007 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Volume 16, Issue 5 , Pages 216-219, September 2007
